{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8374996", "DateCompleted": {"Year": "1993", "Month": "10", "Day": "21"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "06"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0009-2363", "JournalIssue": {"Volume": "41", "Issue": "7", "PubDate": {"Year": "1993", "Month": "Jul"}}, "Title": "Chemical & pharmaceutical bulletin", "ISOAbbreviation": "Chem Pharm Bull (Tokyo)"}, "ArticleTitle": "Preparation and cytotoxicity of cyclic hexapeptides, RA derivatives.", "Pagination": {"StartPage": "1266", "EndPage": "1269", "MedlinePgn": "1266-9"}, "Abstract": {"AbstractText": ["Several aromatic ring substituent modified RA derivatives were prepared from RA-VII (1), RA-V (8) and RA-II (11), and evaluated for cytotoxicity against P388 leukemia and KB cells. In terms of IC50 values, the C zeta methoxyl group of Tyr-3 greatly influenced the activities, while the substituents at the C zeta position of Tyr-6 were less important. One of the derivatives, Tyr-6-C zeta-deoxyRA-V (9, P388, IC50, 0.0025 micrograms/ml) was nearly as active as RA-VII (1, 0.0013 micrograms/ml), and also expressed promising anti-P388 in vivo activity (test/control = 171%, at 25 mg/kg)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tokyo College of Pharmacy, Japan."}], "LastName": "Itokawa", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kondo", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hitotsuyanagi", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nakamura", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Morita", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Takeya", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Chem Pharm Bull (Tokyo)", "NlmUniqueID": "0377775", "ISSNLinking": "0009-2363"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides, Cyclic"}, {"RegistryNumber": "HVM25O0351", "NameOfSubstance": "RA VII"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "KB Cells"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia P388"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred Strains"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Peptides, Cyclic"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1993", "Month": "7", "Day": "1"}, {"Year": "1993", "Month": "7", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1993", "Month": "7", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8374996", "10.1248/cpb.41.1266"]}}]}